| HLC176E (Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets) |
| CyberKnife |
|
A fully robotic image-guided linear accelerator. Delivers SRS and SBRT treatments anywhere in the body with precision and AI-driven real-time motion synchronization. CyberKnife is approved for treating a variety of cancers, including brain tumors, breast, liver, lung, pancreatic and prostate cancers. The system features motion-adaptive delivery technology. It can continuously track and adjust for any movement of the tumor or the patient's body during treatment. This real-time tracking system ensures that the radiation beams accurately target the cancer, even if the tumor or the patient moves slightly during the procedure. CyberKnife System enables smaller treatment margins around the malignant cells, minimizing damage to healthy tissue. |
| Radixact |
|
Radiotherapy delivery system. The megavoltage x-ray radiation is delivered using rotational, non-rotational, intensity modulated (IMRT), 3D CRT treatment techniques and using image-guided (IGRT) or non-image-guided workflows in accordance with the physician-approved plan. The Radixact system integrates surface-guided radiation therapy (SGRT) for patient setup, patient position and motion monitoring, and breath-hold gating. |
|
